BR112012021805A2 - dispositivo de eletroporação de pele tolerável e minimamente invasivo - Google Patents

dispositivo de eletroporação de pele tolerável e minimamente invasivo

Info

Publication number
BR112012021805A2
BR112012021805A2 BR112012021805A BR112012021805A BR112012021805A2 BR 112012021805 A2 BR112012021805 A2 BR 112012021805A2 BR 112012021805 A BR112012021805 A BR 112012021805A BR 112012021805 A BR112012021805 A BR 112012021805A BR 112012021805 A2 BR112012021805 A2 BR 112012021805A2
Authority
BR
Brazil
Prior art keywords
tolerable
electroporation device
minimally invasive
invasive skin
skin electroporation
Prior art date
Application number
BR112012021805A
Other languages
English (en)
Inventor
Feng Lin
Jay Mccoy
Kate Broderick
Rune Kjeken
Stephen V Kemmerrer
Original Assignee
Inovio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inovio Pharmaceuticals Inc filed Critical Inovio Pharmaceuticals Inc
Publication of BR112012021805A2 publication Critical patent/BR112012021805A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0502—Skin piercing electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

dispositivo de eletroporação de pele tolerável e minimamente invasivo. um novo dispositivo de eletroporação para o fornecimento de vacinas que é eficaz tanto na geração de uma resposta imune protetora quanto no fornecimento tolerável a um indivíduo (ou quase indolor); e também métodos de utilização do mesmo dispositivo para vacinar um indivíduo contra uma variedade de doenças infecciosas e tipos de câncer de forma quase indolor.
BR112012021805A 2010-03-01 2011-03-01 dispositivo de eletroporação de pele tolerável e minimamente invasivo BR112012021805A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30942210P 2010-03-01 2010-03-01
PCT/US2011/026701 WO2011109406A1 (en) 2010-03-01 2011-03-01 A tolerable and minimally invasive skin electroporation device

Publications (1)

Publication Number Publication Date
BR112012021805A2 true BR112012021805A2 (pt) 2016-05-17

Family

ID=44542539

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021805A BR112012021805A2 (pt) 2010-03-01 2011-03-01 dispositivo de eletroporação de pele tolerável e minimamente invasivo

Country Status (16)

Country Link
US (2) US11565107B2 (pt)
EP (1) EP2542300B1 (pt)
JP (1) JP5706451B2 (pt)
KR (1) KR101872408B1 (pt)
CN (1) CN102905755B (pt)
AU (1) AU2011223753B2 (pt)
BR (1) BR112012021805A2 (pt)
CA (1) CA2789736A1 (pt)
DK (1) DK2542300T3 (pt)
EA (1) EA025705B1 (pt)
ES (1) ES2594498T3 (pt)
HK (1) HK1181339A1 (pt)
MX (1) MX2012009986A (pt)
PL (1) PL2542300T3 (pt)
PT (1) PT2542300T (pt)
WO (1) WO2011109406A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014524796A (ja) * 2011-06-28 2014-09-25 イノビオ ファーマシューティカルズ，インコーポレイティド 低侵襲表皮電気穿孔装置
AU2015203882C1 (en) * 2011-06-28 2017-09-21 Inovio Pharmaceuticals, Inc. A minimally invasive dermal electroporation device
US11013917B2 (en) 2013-06-21 2021-05-25 Newsouth Innovations Pty Limited Method and apparatus for close-field electroporation
CN104689478A (zh) * 2013-12-09 2015-06-10 深圳市瑞吉思科技有限公司 细胞再生仪
CN103861202B (zh) 2014-03-18 2016-06-01 苏州壹达生物科技有限公司 一种利用空心电极针电穿孔给药的装置
CA2981474A1 (en) * 2015-03-31 2016-10-06 Oncosec Medical Incorporated Systems and methods for improved tissue-sensing based electroporation
ES2970438T3 (es) 2015-12-30 2024-05-28 Inovio Pharmaceuticals Inc Dispositivo de electroporación con conjunto de agujas desmontable con sistema de bloqueo
US11390840B2 (en) * 2016-09-30 2022-07-19 University Of Florida Research Foundation, Inc. Systems and methods including porous membrane for low-voltage continuous cell electroporation
CN107890608A (zh) * 2017-12-01 2018-04-10 王嘉浩 淋巴细胞增升仪
CA3124709A1 (en) * 2019-02-04 2020-08-13 Rutgers, The State University Of New Jersey Device and method for tissue electrotransfer using a microelectrode
US11071860B2 (en) 2019-02-06 2021-07-27 Oncosec Medical Incorporated Systems and methods for detecting fault conditions in electroporation therapy
BR102019013578A2 (pt) * 2019-06-28 2021-01-05 Eqt Equipamentos E Tecnologia Ltda. Ponta aplicadora de eletroporação para procedimento de eletroquimioterapia
KR102576604B1 (ko) 2021-02-16 2023-09-08 주식회사 밀알 의료용 정밀 약물주입 및 전기천공 융합 전극
KR20220159203A (ko) 2021-05-25 2022-12-02 주식회사 밀알 의료용 정밀 약물주입 및 전기천공 융합 전극

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994287A (en) * 1974-07-01 1976-11-30 Centre De Recherche Industrielle Du Quebec Trocar
US6277116B1 (en) * 1994-05-06 2001-08-21 Vidaderm Systems and methods for shrinking collagen in the dermis
US6183434B1 (en) * 1996-07-03 2001-02-06 Spectrx, Inc. Multiple mechanical microporation of skin or mucosa
US6241701B1 (en) * 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
TW368420B (en) * 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US7922709B2 (en) * 1998-07-13 2011-04-12 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
EP1163024B1 (en) 1999-01-28 2003-12-17 Cyto Pulse Sciences, Inc. Delivery of macromolecules into cells
US6678558B1 (en) * 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
US7113821B1 (en) * 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US20070016268A1 (en) 2000-01-07 2007-01-18 John Carter Percutaneous electrode array
US7245963B2 (en) * 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US6912417B1 (en) 2002-04-05 2005-06-28 Ichor Medical Systmes, Inc. Method and apparatus for delivery of therapeutic agents
AU2003226605A1 (en) * 2002-04-19 2003-11-03 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US20060036210A1 (en) 2004-06-30 2006-02-16 Lei Zhang Modular electroporation device with disposable electrode and drug delivery components
US20100168501A1 (en) * 2006-10-02 2010-07-01 Daniel Rogers Burnett Method and apparatus for magnetic induction therapy
KR101385865B1 (ko) 2006-02-11 2014-04-17 제네트로닉스, 인코포레이티드 싱글-니들 생체내 일렉트로포레이션용 장치
CN101563132A (zh) * 2006-10-17 2009-10-21 Vgx药品公司 电穿孔装置及用其进行哺乳动物细胞电穿孔的方法
WO2008094664A1 (en) 2007-01-31 2008-08-07 Adam Heller Methods and compositions for the treatment of pain

Also Published As

Publication number Publication date
KR20130020662A (ko) 2013-02-27
EP2542300A4 (en) 2013-11-13
EA201201203A1 (ru) 2013-04-30
US20130066296A1 (en) 2013-03-14
EP2542300B1 (en) 2016-08-10
KR101872408B1 (ko) 2018-06-28
PL2542300T3 (pl) 2017-06-30
MX2012009986A (es) 2012-11-21
WO2011109406A1 (en) 2011-09-09
AU2011223753B2 (en) 2014-06-26
JP5706451B2 (ja) 2015-04-22
PT2542300T (pt) 2016-11-14
DK2542300T3 (en) 2016-11-28
US20230145532A1 (en) 2023-05-11
HK1181339A1 (zh) 2013-11-08
EP2542300A1 (en) 2013-01-09
CA2789736A1 (en) 2011-09-09
CN102905755A (zh) 2013-01-30
CN102905755B (zh) 2016-03-09
ES2594498T3 (es) 2016-12-20
US11565107B2 (en) 2023-01-31
AU2011223753A1 (en) 2012-09-13
JP2013521058A (ja) 2013-06-10
EA025705B1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
BR112012021805A2 (pt) dispositivo de eletroporação de pele tolerável e minimamente invasivo
AR117136A2 (es) Aparato generador electrohidráulico (eh) de ondas de choque de pulsos rápidos, y métodos para tratamientos médicos y cosméticos
CO7151524A2 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciación y usos de los mismos
MX369616B (es) Composiciones cutaneas y metodos para su uso.
MX2015011296A (es) Dispositivo foto-terapeutico, metodo y uso.
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
MX347471B (es) Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas.
MX345704B (es) Vacuna bovinas y métodos.
CL2016000544A1 (es) Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel.
PE20151588A1 (es) Vacuna contra el virus del dengue
BR102014006335B8 (pt) Método para produzir uma população isolada de células-tronco de polpa dentária imaturas (idpscs) e uso
BR112014002595A2 (pt) uso de esfinganina para melhorar a aparência visual da pele e cabelo
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
BR112015021523A8 (pt) composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
BR112014001409A2 (pt) métodos e composições para vacinação contra staphylococcus aureus
BR112015029815A2 (pt) composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo.
BR112018008697A2 (pt) método e kit para vacinação contra um auto-antígeno, uso de um kit, e, vacina para uso em vacinação.
PH12015502844A1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
MX2017015418A (es) Composiciones y metodos de uso de beta-hidroxi-beta-metilbutirato (hmb) para reducir grasa corporal.
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
ATE529131T1 (de) Impfung mittels gezielter transkutaner freisetzung
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso
BR112013006245A2 (pt) vacina e método para vacinação
ES2670493T3 (es) Vacuna de MTB-C contra respuestas alérgicas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]